SYN608
/ SynRx Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 29, 2025
Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors
(clinicaltrials.gov)
- P1 | N=105 | Not yet recruiting | Sponsor: Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
New P1 trial • Platinum resistant • Breast Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Ovarian Cancer • Solid Tumor • BRCA
1 to 1
Of
1
Go to page
1